HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Harvey A Tatum Selected Research

peginterferon alfa-2a (Pegasys)

2/2015Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection.
9/2012Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Harvey A Tatum Research Topics

Disease

3Infections
06/2015 - 09/2012
3Chronic Hepatitis C
06/2015 - 09/2012
1Fibrosis (Cirrhosis)
09/2012

Drug/Important Bio-Agent (IBA)

3daclatasvirIBA
06/2015 - 09/2012
3Ribavirin (Virazole)FDA LinkGeneric
06/2015 - 09/2012
2peginterferon alfa-2a (Pegasys)FDA Link
02/2015 - 09/2012
1N 30IBA
06/2015
1Antiviral Agents (Antivirals)IBA
09/2012

Therapy/Procedure

1Therapeutics
02/2015
1Duration of Therapy
02/2015